22nd Century Group Company Profile (NYSE:XXII)

About 22nd Century Group (NYSE:XXII)

22nd Century Group logo22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: Mining Support Activities
  • Sub-Industry: N/A
  • Symbol: NYSE:XXII
  • CUSIP: N/A
  • Web: www.xxiicentury.com/
Capitalization:
  • Market Cap: $170.88 million
  • Outstanding Shares: 90,895,000
Average Prices:
  • 50 Day Moving Avg: $1.51
  • 200 Day Moving Avg: $1.17
  • 52 Week Range: $0.77 - $2.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -18.80
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $11.49 million
  • Price / Sales: 14.87
  • Book Value: $0.24 per share
  • Price / Book: 7.83
Profitability:
  • EBIDTA: ($10,260,000.00)
  • Net Margins: -117.47%
  • Return on Equity: -45.50%
  • Return on Assets: -39.67%
Misc:
  • Average Volume: 1.15 million shs.
  • Short Ratio: 4.97
 

Frequently Asked Questions for 22nd Century Group (NYSE:XXII)

What is 22nd Century Group's stock symbol?

22nd Century Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "XXII."

How were 22nd Century Group's earnings last quarter?

22nd Century Group Inc (NYSE:XXII) announced its quarterly earnings results on Tuesday, May, 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01. The company earned $3.02 million during the quarter. 22nd Century Group had a negative net margin of 117.47% and a negative return on equity of 45.50%. View 22nd Century Group's Earnings History.

Where is 22nd Century Group's stock going? Where will 22nd Century Group's stock price be in 2017?

1 analysts have issued 12-month target prices for 22nd Century Group's stock. Their forecasts range from $3.50 to $3.50. On average, they expect 22nd Century Group's share price to reach $3.50 in the next year. View Analyst Ratings for 22nd Century Group.

What are analysts saying about 22nd Century Group stock?

Here are some recent quotes from research analysts about 22nd Century Group stock:

  • 1. According to Zacks Investment Research, "22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York. " (5/24/2017)
  • 2. Chardan Capital analysts commented, "We expect 22nd Century to report Q4 results this week. Our revenue estimate for the quarter is $3.1 million, equivalent to Q3 results. For the full year this results in revenue of $12 million. We expect the company on its earnings call to focus on recent communications with the FDA regarding its PMTA (Premarket Tobacco Product Applications), the MRTP (Modified Risk Tobacco Product) applications and a path forward for X-22. Earlier this month the FDA granted a guidance meeting to discuss X-22 and the ways 22nd Century could attempt to win approval for X-22 as a prescription-based aid for smoking cessation. The company has also received written feedback on the MRTP application for Brand A, the company's very low nicotine (VLN) cigarette. As we progress through the year we expect additional milestones to be reached on 22nd Century's attempt to use its proprietary technology to create VLN products for the smoking cessation market." (3/7/2017)

Are investors shorting 22nd Century Group?

22nd Century Group saw a increase in short interest in May. As of May 31st, there was short interest totalling 4,458,840 shares, an increase of 0.7% from the May 15th total of 4,428,859 shares. Based on an average daily volume of 313,189 shares, the days-to-cover ratio is currently 14.2 days. Currently, 6.1% of the company's stock are sold short.

Who are some of 22nd Century Group's key competitors?

Who are 22nd Century Group's key executives?

22nd Century Group's management team includes the folowing people:

  • Henry Sicignano III, President, Chief Executive Officer, Director
  • John T. Brodfuehrer, Chief Financial Officer, Treasurer
  • Thomas L. James Esq., Vice President, General Counsel, Secretary
  • Paul Rushton Ph.D., Vice President - Plant Biotechnology
  • Michael R. Moynihan Ph.D., Vice President - Research & Development
  • James W. Cornell, Non-Executive Independent Chairman of the Board
  • Nora B. Sullivan, Director
  • Joseph Alexander Dunn Ph.D., Independent Director
  • Richard M. Sanders, Independent Director

Who owns 22nd Century Group stock?

22nd Century Group's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (2.71%), Geode Capital Management LLC (0.49%) and National Asset Management Inc. (0.19%). Company insiders that own 22nd Century Group stock include John T Brodfuehrer, Joseph Pandolfino and Michael Robert Moynihan. View Institutional Ownership Trends for 22nd Century Group.

Who bought 22nd Century Group stock? Who is buying 22nd Century Group stock?

22nd Century Group's stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc. and National Asset Management Inc.. View Insider Buying and Selling for 22nd Century Group.

How do I buy 22nd Century Group stock?

Shares of 22nd Century Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 22nd Century Group's stock price today?

One share of 22nd Century Group stock can currently be purchased for approximately $1.88.


MarketBeat Community Rating for 22nd Century Group (NYSE XXII)
Community Ranking:  2.4 out of 5 ( )
Outperform Votes:  39 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  82
MarketBeat's community ratings are surveys of what our community members think about 22nd Century Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for 22nd Century Group (NYSE:XXII) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.50 (86.17% upside)

Analysts' Ratings History for 22nd Century Group (NYSE:XXII)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/7/2017Chardan CapitalReiterated RatingBuy$3.50N/AView Rating Details
(Data available from 6/25/2015 forward)

Earnings

Earnings History for 22nd Century Group (NYSE:XXII)
Earnings by Quarter for 22nd Century Group (NYSE:XXII)
Earnings History by Quarter for 22nd Century Group (NYSE XXII)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2016Q1($0.03)($0.04)$3.02 millionViewN/AView Earnings Details
11/9/2015Q3($0.03)($0.04)$2.67 millionViewN/AView Earnings Details
8/4/2015Q215($0.02)($0.02)$1.30 million$2.31 millionViewN/AView Earnings Details
2/6/2015($0.03)($0.09)ViewN/AView Earnings Details
11/14/2014Q314($0.03)($0.05)$0.06 millionViewN/AView Earnings Details
8/14/2014($0.03)($0.03)$0.02 millionViewN/AView Earnings Details
5/2/2014($0.03)($0.09)$0.45 millionViewN/AView Earnings Details
1/30/2014Q4($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for 22nd Century Group (NYSE:XXII)
Current Year EPS Consensus Estimate: $-0.09 EPS
Next Year EPS Consensus Estimate: $-0.10 EPS

Dividends

Dividend History for 22nd Century Group (NYSE:XXII)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for 22nd Century Group (NYSE:XXII)
Insider Trades by Quarter for 22nd Century Group (NYSE:XXII)
Institutional Ownership by Quarter for 22nd Century Group (NYSE:XXII)
Insider Trades by Quarter for 22nd Century Group (NYSE:XXII)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/8/2017Michael Robert MoynihanVPSell20,468$2.00$40,936.00View SEC Filing  
10/31/2016Michael Robert MoynihanVPSell100,000$1.28$128,000.00View SEC Filing  
3/29/2016John T BrodfuehrerCFOBuy12,500$0.77$9,625.00View SEC Filing  
11/3/2015Michael Robert MoynihanVPSell50,000$1.40$70,000.00View SEC Filing  
6/30/2015Joseph PandolfinoDirectorSell91,178$0.95$86,619.10View SEC Filing  
12/31/2014Joseph PandolfinoDirectorSell105,124$1.65$173,454.60View SEC Filing  
12/26/2014Joseph PandolfinoDirectorSell41,722$1.54$64,251.88View SEC Filing  
12/22/2014Joseph PandolfinoDirectorSell52,683$1.60$84,292.80View SEC Filing  
12/17/2014Joseph PandolfinoDirectorSell75,768$1.62$122,744.16View SEC Filing  
12/11/2014Joseph PandolfinoDirectorSell67,836$1.65$111,929.40View SEC Filing  
5/9/2014Richard M SandersDirectorBuy20,000$2.23$44,600.00View SEC Filing  
4/23/2014Michael Robert MoynihanVPSell100,000$2.44$244,000.00View SEC Filing  
3/12/2014Joseph PandolfinoCEOSell95,000$5.73$544,350.00View SEC Filing  
12/10/2013Clearwater Partners, LlcMajor ShareholderSell10,000$1.55$15,500.00View SEC Filing  
12/3/2013Clearwater Partners, LlcMajor ShareholderSell10,000$1.35$13,500.00View SEC Filing  
11/19/2013Clearwater Partners, LlcMajor ShareholderSell30,074$1.09$32,780.66View SEC Filing  
11/13/2013Clearwater Partners, LlcMajor ShareholderSell11,826$0.98$11,589.48View SEC Filing  
11/11/2013Clearwater Partners, LlcMajor ShareholderSell7,100$1.03$7,313.00View SEC Filing  
11/7/2013Clearwater Partners, LlcMajor ShareholderSell9,000$1.15$10,350.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for 22nd Century Group (NYSE:XXII)
Latest Headlines for 22nd Century Group (NYSE:XXII)
Source:
DateHeadline
streetinsider.com logo22nd Century Group (XXII) Receives Guidance from FDA on Phase III Clinical Trials for Prescription-Based Smoking Cessation Product
www.streetinsider.com - June 23 at 8:23 PM
streetinsider.com logo22nd Century Group (XXII) Receives Guidance from FDA on Phase ... - StreetInsider.com
www.streetinsider.com - June 22 at 2:54 PM
finance.yahoo.com logo22nd Century Receives Guidance from FDA on Phase III Clinical Trials
finance.yahoo.com - June 22 at 2:54 PM
businesswire.com logo22nd Century Partners with The University of Virginia to Utilize Industrial Hemp to Clean Up and Reclaim Polluted Lands - Business Wire (press release)
www.businesswire.com - June 20 at 3:44 PM
finance.yahoo.com logo22nd Century Partners with The University of Virginia to Utilize Industrial Hemp to Clean Up and Reclaim Polluted Lands
finance.yahoo.com - June 20 at 3:44 PM
streetinsider.com logo22nd Century Group (XXII) Meets with FDA on Modified Risk Tobacco Product Application For Low Nicotine Tobacco Cigarettes
www.streetinsider.com - June 18 at 12:12 AM
streetinsider.com logo22nd Century Group (XXII) Meets with FDA on Modified Risk ... - StreetInsider.com
www.streetinsider.com - June 17 at 8:01 AM
finance.yahoo.com logo22nd Century Meets with FDA on Modified Risk Tobacco Product Application for World’s Lowest Nicotine Tobacco Cigarettes
finance.yahoo.com - June 17 at 8:01 AM
finance.yahoo.com logoNew International Survey Shows Overwhelming Support for Very Low Nicotine Cigarettes
finance.yahoo.com - June 15 at 4:14 PM
americanbankingnews.com logoZacks: 22nd Century Group Inc (XXII) Given $3.50 Consensus Target Price by Analysts
www.americanbankingnews.com - June 14 at 10:54 AM
americanbankingnews.com logo22nd Century Group Inc (XXII) VP Sells $40,936.00 in Stock
www.americanbankingnews.com - June 9 at 8:21 PM
finanznachrichten.de logoOnline Media Group, Inc.: 22nd Century Group Stock Climbs to 2-1/2 Year High
www.finanznachrichten.de - June 9 at 2:56 AM
finance.yahoo.com logo22nd Century Group (XXII) Jumps: Stock Adds 12.2% in Session
finance.yahoo.com - June 9 at 2:56 AM
finance.yahoo.com logo22nd Century and Dent Neurosciences Research Center to Partner on Brain Imaging Clinical Trial
finance.yahoo.com - June 9 at 2:56 AM
finance.yahoo.com logoToday's Research Reports on Stocks to Watch: Egalet Corporation and 22nd Century Group
finance.yahoo.com - June 8 at 2:15 AM
finance.yahoo.com logo22nd Century Produces Non-GMO Very Low Nicotine Tobacco
finance.yahoo.com - June 7 at 1:25 AM
prnewswire.com logoBiotech Stock Performance Review -- 22nd Century, Calithera Biosciences, Five ...
www.prnewswire.com - June 5 at 9:30 AM
businesswire.com logo22nd Century Group Receives Order for 2.4 Million SPECTRUM ... - Business Wire (press release)
www.businesswire.com - June 2 at 7:56 AM
finance.yahoo.com logo22nd Century Group Receives Order for 2.4 Million SPECTRUM® U.S. Government Research Cigarettes
finance.yahoo.com - June 2 at 7:56 AM
businesswire.com logoDramatic Surge in Very Low Nicotine Tobacco Clinical Trials and Science - Business Wire (press release)
www.businesswire.com - June 1 at 5:50 AM
finance.yahoo.com logoDramatic Surge in Very Low Nicotine Tobacco Clinical Trials and Science
finance.yahoo.com - May 31 at 11:30 AM
seekingalpha.com logo22nd Century: No Harm Owning This Stock - Seeking Alpha
seekingalpha.com - May 30 at 3:15 PM
americanbankingnews.com logo 22nd Century Group Inc (XXII) Given $3.50 Consensus Target Price by Brokerages
www.americanbankingnews.com - May 26 at 2:28 PM
americanbankingnews.com logo22nd Century Group Inc (XXII) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - May 24 at 7:54 AM
americanbankingnews.com logo22nd Century Group Inc (XXII) Downgraded by Zacks Investment Research
www.americanbankingnews.com - May 17 at 11:00 AM
businesswire.com logo22nd Century Raises 2017 Revenue Projection to $16Million – Another Record Year - Business Wire (press release)
www.businesswire.com - May 11 at 3:22 PM
americanbankingnews.com logoShort Interest in 22nd Century Group Inc (XXII) Drops By 7.3%
www.americanbankingnews.com - May 10 at 7:02 AM
finance.yahoo.com logo22nd Century Raises 2017 Revenue Projection to $16Million – Another Record Year
finance.yahoo.com - May 9 at 8:39 AM
finance.yahoo.com logo22nd Century Group Files 2017 First Quarter Report and Announces Conference Call to Provide Business Update
finance.yahoo.com - May 8 at 8:58 PM
americanbankingnews.com logo22nd Century Group Inc (XXII) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - May 5 at 8:08 PM
americanbankingnews.com logo 22nd Century Group Inc (XXII) Receives Consensus Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - May 4 at 9:16 AM
americanbankingnews.com logoVery Favorable News Coverage Very Likely to Affect 22nd Century Group (XXII) Share Price
www.americanbankingnews.com - May 2 at 10:40 AM
streetinsider.com logoPre-Open Movers 05/01: (OCN) (XXII) (TWTR) Higher; (FNBC) (AEZS) (ITCI) Lower (more...)
www.streetinsider.com - May 1 at 7:50 PM
streetinsider.com logo22nd Century Group (XXII) Receives FDA Clearance for Trial of BRAND B Low Tar-to-Nicotine Ratio Cigarettes - StreetInsider.com
www.streetinsider.com - May 1 at 9:31 AM
finance.yahoo.com logoFDA Authorizes Clinical Trial for 22nd Century’s BRAND B Low Tar-to-Nicotine Ratio Cigarettes
finance.yahoo.com - May 1 at 9:31 AM
americanbankingnews.com logoFavorable Media Coverage Very Likely to Affect 22nd Century Group (XXII) Stock Price
www.americanbankingnews.com - April 29 at 9:20 AM
americanbankingnews.com logoPositive Media Coverage Unlikely to Affect 22nd Century Group (XXII) Stock Price
www.americanbankingnews.com - April 26 at 8:12 AM
americanbankingnews.com logo22nd Century Group Inc (XXII) Short Interest Update
www.americanbankingnews.com - April 25 at 8:48 PM
finance.yahoo.com logo22nd Century Accepted to Present Proprietary Smoking Cessation Product at BIOCHINA Partnering Forum in Zhuhai, China
finance.yahoo.com - April 25 at 7:41 PM
americanbankingnews.com logo22nd Century Group (XXII) Receives Coverage Optimism Score of 0.40
www.americanbankingnews.com - April 22 at 8:53 AM
finance.yahoo.com logo22nd Century Will Play Leading Role in Industrial Hemp Industry
finance.yahoo.com - April 21 at 1:26 AM
americanbankingnews.com logo22nd Century Group (XXII) Earning Positive News Coverage, AlphaOne Reports
www.americanbankingnews.com - April 19 at 9:09 AM
americanbankingnews.com logoZacks: 22nd Century Group Inc (XXII) Receives Average Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - April 18 at 10:32 AM
americanbankingnews.com logoSomewhat Positive News Coverage Likely to Impact 22nd Century Group (XXII) Share Price
www.americanbankingnews.com - April 16 at 8:50 AM
americanbankingnews.com logoFavorable Press Coverage Very Likely to Impact 22nd Century Group (XXII) Stock Price
www.americanbankingnews.com - April 13 at 9:25 AM
americanbankingnews.com logo22nd Century Group Inc (XXII) Short Interest Down 2.9% in March
www.americanbankingnews.com - April 12 at 7:05 AM
finance.yahoo.com logoNew Zealand Study Recommends 22nd Century’s VLN Cigarettes as an Effective Tobacco Control Strategy
finance.yahoo.com - April 7 at 1:39 PM
finance.yahoo.com logoCan The Uptrend Continue for 22nd Century Group (XXII)?
finance.yahoo.com - April 7 at 1:39 PM
americanbankingnews.com logo 22nd Century Group Inc (XXII) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - April 6 at 9:52 AM
thestreet.com logoCollect Smokin' Hot Profits From This Marijuana Biotech
www.thestreet.com - March 30 at 8:37 PM

Social

Chart

22nd Century Group (XXII) Chart for Sunday, June, 25, 2017

This page was last updated on 6/25/2017 by MarketBeat.com Staff